Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01224652
What this trial is testing

Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy

Who this might be right for
Gastric Cancer
Korean Cancer Study Group 518
Testing effectiveness (Phase 2)Study completedNCT00182806
What this trial is testing

Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 38
Early research (Phase 1)Study completedNCT01383538
What this trial is testing

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinomaPancreatic Neoplasms
Andrew Ko 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05969899
What this trial is testing

Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fudan University 50
Testing effectiveness (Phase 2)Study completedNCT01114555
What this trial is testing

Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 34
Early research (Phase 1)Study completedNCT00993044
What this trial is testing

Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin

Who this might be right for
Refractory Solid Tumors in Children
Children's Hospital Los Angeles 13
Large-scale testing (Phase 3)Study completedNCT02564263
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 628
Testing effectiveness (Phase 2)UnknownNCT00043199
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20
Testing effectiveness (Phase 2)Study completedNCT00332163
What this trial is testing

Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

Who this might be right for
Metastatic Colorectal CancerSkin RashSkin Toxicities+2 more
Amgen 95
Large-scale testing (Phase 3)Study completedNCT00142350
What this trial is testing

5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Japan Clinical Oncology Group 690
Testing effectiveness (Phase 2)Study completedNCT00475293
What this trial is testing

Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 85
Not applicableUnknownNCT05688033
What this trial is testing

Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy

Who this might be right for
Rectal Cancer
Fudan University 200
Testing effectiveness (Phase 2)Study completedNCT01767194
What this trial is testing

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Who this might be right for
GanglioneuroblastomaRecurrent Neuroblastoma
National Cancer Institute (NCI) 73
Early research (Phase 1)Study completedNCT00004051
What this trial is testing

Irinotecan in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06763029
What this trial is testing

Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Fudan University 36
Early research (Phase 1)Ended earlyNCT04627142
What this trial is testing

Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Boehringer Ingelheim 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT07803783
What this trial is testing

Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy

Who this might be right for
Metastatic Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
MediLink Therapeutics (Suzhou) Co., Ltd. 320
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04901741
What this trial is testing

Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
TME Pharma AG 60
Large-scale testing (Phase 3)Looking for participantsNCT06496048
What this trial is testing

Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC

Who this might be right for
Relapsed Small Cell Lung Cancer
Luye Pharma Group Ltd. 180
Next Page